This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in June and July, including the first over-the-counter, nonprescription daily oral contraceptive, the first monoclonal...
A recent study examined the effectiveness of a test that uses measurement of compounds found in saliva to predict the risk of developing Alzheimer's disease.
A recent study examined the effectiveness of a test that uses measurement of compounds found in saliva to predict the risk of developing Alzheimer's disease.
A team led by UCLA researchers have validated a technique they say is the first “gold standard” for measuring atrophy in the brain’s hippocampus, an early indicator of Alzheimer’s disease.
A team led by UCLA researchers have validated a technique they say is the first “gold standard” for measuring atrophy in the brain’s hippocampus, an early indicator of Alzheimer’s disease.
Researchers at the Mayo Clinic have identified a very simple new scoring system that may be helpful in predicting which elderly patients are at risk of developing mild cognitive impairment.
